Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 1 de 1
过滤器
添加過濾器








年份範圍
1.
Acta cir. bras ; Acta cir. bras;29(11): 696-702, 11/2014. tab, graf
文章 在 英语 | LILACS | ID: lil-728643

摘要

PURPOSE: To explore the mechanism of resistance to IKKβ inhibitor in multiple myeloma (MM) cells and uncover novel therapeutic targets for MM. METHODS: We downloaded the microarray data (GSE8476) from GEO (Gene Expression Omnibus) database. The data were derived from the human MM cells lines (L363 cells) treated with IKKβ inhibitor MLN120b (MLN) for eight, 12 and 24 hours. Furthermore, we applied the Search Tool for the Retrieval of Interacting Genes (STRING) and Expression Analysis Systematic Explorer (EASE) database to construct protein-protein interaction networks and identified over-represented pathway among DEGs (differentially expressed genes). RESULTS: We obtained 108 DGEs in 8h vs. 12h group and 101 ones in 8h vs. 24h group. Most of DGEs were found to be involved in biological regulation. The significant pathways were Ig A pathway and the CAMs pathways. In addition, 24 common DGEs were found in the networks of the two groups such as ICAM 3 and SELL. CONCLUSION: Intercellular adhesion molecule 3 and SELL may be potential targets in multiple myeloma treatment in the future. .


Subject(s)
Humans , Gene Targeting/methods , I-kappa B Kinase/antagonists & inhibitors , Multiple Myeloma/drug therapy , Multiple Myeloma/genetics , Oligonucleotide Array Sequence Analysis/methods , Cell Adhesion , Cell Line, Tumor , Cluster Analysis , I-kappa B Kinase/metabolism , Multiple Myeloma/metabolism , Reproducibility of Results , Time Factors
搜索明细